US PRE-MARKET MOVERS: GS, LEG, TLX, ON, BX, SNDK, BKR, CSGP, BBY, GFL, REPL

The pre-market movers suggest a risk-off sentiment in equities, particularly influenced by Goldman Sachs' notable decline of 3.8% due to disappointing trading revenues and increased credit loss provisions, despite topping EPS and NII expectations.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Six railway facilities targeted in strikes last week have been rebuilt in Iran, state TV reports

US military says blockade will be enforced in the Gulf of Oman and Arabian Sea east of the Strait of Hormuz and blockade applies to all vessel traffic, regardless of flag, according to a note sent to seafarers

US PRE-MARKET MOVERS: GS, LEG, TLX, ON, BX, SNDK, BKR, CSGP, BBY, GFL, REPL

PRIMER - Today's Fedspeak: Miran

Goldman Sachs (GS) Q1 2026 (USD): EPS 17.55 (exp. 16.41), Revenue 17.2bln (exp. 16.95bln)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

ES -0.7% NQ -0.7% RTY -1%

  • Mag-7: MSFT -0.3% AAPL -0.5% TSLA -0.6% AMZN -1% META -1.1% GOOGL -1.1% NVDA -1.4%
  • GS -3.8%: FICC sales & trading rev. light & provision for credit losses rises; note, EPS, rev., NII topped
  • LEG +6.7%: To be acquired by SGI in an all-stock transaction valued at approx. $2.5bln
  • TLX +3.5%: W/ REGN to co-develop & co-commercialise next-gen radiopharmaceutical therapies; TLX to receive $40mln upfront & up to $2.1bln in milestones
  • ON +3.2%: Upgraded at BofA
  • BX +2%: Upgraded at Oppenheimer
  • SNDK +1.6%: Will join the Nasdaq 100 index, replacing TEAM, effective BMO on 20th April
  • BKR +1%: Will sell Waygate Technologies to Hexagon for c. $1.45bln
  • CSGP -0.1%: Third Point will not pursue a proxy fight at CoStar & sold its entire stake
  • BBY -3.3%: Downgraded at Goldman
  • GFL -3.8%: Confirmed to buy Secure Waste Infrastructure for more than CAD 6bln, incl. debt
  • REPL -62%: FDA rejected its melanoma treatment
Context

In contrast, LEG's +6.7% jump from its acquisition announcement highlights robust M&A activity, which could inspire investor optimism in the sector. Overall, this divergent performance underscores the mixed sentiment in the market as investors weigh earnings results against broader trends.

Related headlines

The whole workspace, free to try.

Try it free